🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/09/2023 | 222,14 | 225,36 | 220,63 | 224,06 | +0,59% | 2,13% | 300.200 |
| 22/09/2023 | 223,72 | 225,00 | 221,82 | 222,75 | -0,42% | 1,42% | 163.700 |
| 21/09/2023 | 223,93 | 224,61 | 220,94 | 223,68 | -0,11% | 1,64% | 211.700 |
| 20/09/2023 | 222,49 | 226,58 | 220,97 | 223,93 | +1,48% | 2,52% | 285.400 |
| 19/09/2023 | 217,32 | 221,52 | 216,42 | 220,67 | +1,47% | 2,35% | 226.000 |
| 18/09/2023 | 221,00 | 221,58 | 217,11 | 217,48 | -1,25% | 2,02% | 308.800 |
| 15/09/2023 | 218,85 | 221,07 | 218,85 | 220,24 | +0,34% | 1,01% | 656.300 |
| 14/09/2023 | 223,51 | 224,09 | 218,78 | 219,49 | -1,28% | 2,38% | 275.500 |
| 13/09/2023 | 223,27 | 224,64 | 220,76 | 222,34 | -0,64% | 1,74% | 270.500 |
| 12/09/2023 | 226,95 | 226,95 | 222,60 | 223,78 | -0,68% | 1,92% | 149.100 |
| 11/09/2023 | 224,98 | 225,94 | 223,62 | 225,32 | +0,08% | 1,03% | 165.700 |
| 08/09/2023 | 223,15 | 225,45 | 221,81 | 225,13 | +1,12% | 1,63% | 164.200 |
| 07/09/2023 | 223,41 | 224,26 | 221,76 | 222,63 | -0,33% | 1,12% | 266.200 |
| 06/09/2023 | 226,17 | 226,17 | 222,02 | 223,36 | -0,83% | 1,83% | 187.500 |
| 05/09/2023 | 227,13 | 227,13 | 224,02 | 225,23 | -1,24% | 1,37% | 233.200 |
| 01/09/2023 | 226,12 | 229,49 | 225,74 | 228,05 | +1,64% | 1,66% | 253.000 |
| 31/08/2023 | 228,26 | 230,59 | 224,22 | 224,36 | -1,79% | 2,79% | 289.900 |
| 30/08/2023 | 230,01 | 231,14 | 227,80 | 228,44 | -0,47% | 1,45% | 124.100 |
| 29/08/2023 | 226,48 | 229,98 | 224,57 | 229,53 | +1,56% | 2,39% | 174.600 |
| 28/08/2023 | 230,15 | 230,87 | 225,29 | 226,01 | -1,31% | 2,42% | 215.900 |
| 25/08/2023 | 230,61 | 230,61 | 227,90 | 229,01 | -0,66% | 1,18% | 190.900 |
| 24/08/2023 | 231,08 | 233,79 | 229,88 | 230,53 | -0,40% | 1,69% | 146.000 |
| 23/08/2023 | 232,98 | 235,19 | 230,92 | 231,46 | +0,17% | 1,83% | 288.100 |
| 22/08/2023 | 230,55 | 233,93 | 230,00 | 231,06 | -0,03% | 1,70% | 172.600 |
| 21/08/2023 | 230,15 | 231,57 | 228,88 | 231,14 | +0,58% | 1,17% | 237.400 |
| 18/08/2023 | 227,30 | 230,35 | 226,45 | 229,80 | +0,74% | 1,72% | 277.600 |
| 17/08/2023 | 230,81 | 234,75 | 227,41 | 228,12 | -1,15% | 3,18% | 1.170.400 |
| 16/08/2023 | 235,28 | 236,66 | 230,55 | 230,77 | -2,10% | 2,60% | 245.700 |
| 15/08/2023 | 232,45 | 236,82 | 232,07 | 235,73 | +1,06% | 2,04% | 184.700 |
| 14/08/2023 | 236,17 | 237,27 | 232,90 | 233,26 | -1,91% | 1,85% | 1.173.500 |